Yes! Exciting!: This paper was published in a very pretigious medical journal (nature medicine 2012). The vaccine uses different pieces of renal cancer to stimulate the immune system and prevent recurrence. The first clinical trials (phase i and ii) showed improved survival for patients, but before we know if that's "real", a phase iii study must be done. This is underway. I'm hopeful!
Answered 7/24/2013
5.7k views
5 doctors weighed in across 2 answers
8 doctors weighed in across 4 answers
A doctor has provided 1 answer
5 doctors weighed in across 3 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question